Anti-diabetic effects of resveratrol (lowering of FBG, elevated GSIS, and improvements in circulating insulin levels) have been noted in rodent models of hyperglycemia, glucose intolerance, and T2DM [165–167]. This evidence concerns the gene INS and Hyperglycemia.